Loading...
Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial
BACKGROUND: The optimal intravenous (IV) iron would allow safe correction of iron deficiency at a single infusion over a short time. The FERWON-NEPHRO trial evaluated the safety and efficacy of iron isomaltoside 1000/ferric derisomaltose (IIM) in patients with non-dialysis-dependent chronic kidney d...
Na minha lista:
| Udgivet i: | Nephrol Dial Transplant |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7771981/ https://ncbi.nlm.nih.gov/pubmed/32049331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfaa011 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|